Health
Researchers develop novel class of cancer immunotherapy – Drug Target Review
The scientists developed a therapy which uses nanobiologics to train the innate immune system to recognise and combat cancer cells.
Posted: 30 October 2020 | Hannah Balfour (Drug Target Review) | No comments yet
The scientists developed a therapy which uses nanobiologics to train the innate immune system to recognise and combat cancer cells.
Researchers have developed a new type of cancer immunotherapy that uses nanobiologics to train the immune system to eliminate tumour cells. Nanobiologics are tiny materials bioengineered from natural molecules.
The lead candidate, called MTP10-HDL, was developed and tested on murine models…
-
General21 hours agoAshes engulfed by fresh DRS controversy as TV umpire gives Jamie Smith out despite RTS ‘murmur’
-
Noosa News6 hours agoTwo teenagers and two adults rushed to hospital in life-threatening conditions after shocking Lawnton house fire
-
Noosa News6 hours agoFatal traffic crash, Noosa – Sunshine Coast
-
Noosa News22 hours agoBrisbane widow’s $6 million prize home win comes with unexpected luxury